ProfileGDS4718 / 244282_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 74% 54% 47% 74% 75% 25% 28% 53% 76% 77% 71% 60% 44% 32% 24% 48% 62% 21% 25% 23% 69% 64% 65% 80% 64% 51% 76% 32% 83% 30% 25% 23% 62% 58% 24% 25% 25% 62% 57% 25% 63% 22% 37% 45% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.2168974
GSM549102patient 115, normal, homogenized [OPG study]5.7839654
GSM549104patient 119, normal, homogenized [OPG study]5.3580747
GSM549108patient 138, normal, homogenized [OPG study]7.1784474
GSM549119patient 077, normal, homogenized [OPG study]7.2283175
GSM549133patient 032, cancer, homogenized [OPG study]4.2960225
GSM549139patient 042, cancer, homogenized [OPG study]4.4426828
GSM549099patient 107, normal, homogenized [OPG study]5.707653
GSM549109patient 139, normal, homogenized [OPG study]7.3338976
GSM549110patient 046, normal, homogenized [OPG study]7.5185377
GSM549114patient 063, normal, homogenized [OPG study]6.9229371
GSM549122patient 082, normal, homogenized [OPG study]6.1354260
GSM549134patient 033, cancer, homogenized [OPG study]5.1784144
GSM549136patient 036, cancer, homogenized [OPG study]4.5568532
GSM549140patient 044, cancer, homogenized [OPG study]4.2391824
GSM549111patient 047, normal, homogenized [OPG study]5.3629448
GSM549113patient 057, normal, homogenized [OPG study]6.2094862
GSM549132patient 031, cancer, homogenized [OPG study]4.1607821
GSM549137patient 038, cancer, homogenized [OPG study]4.3093325
GSM549142patient 047, cancer, homogenized [OPG study]4.3396123
GSM549100patient 110, normal, homogenized [OPG study]6.7578269
GSM549107patient 135, normal, homogenized [OPG study]6.3706764
GSM549115patient 068, normal, homogenized [OPG study]6.4940465
GSM549116patient 072, normal, homogenized [OPG study]7.9418280
GSM549120patient 078, normal, homogenized [OPG study]6.3949364
GSM549131patient 030, cancer, homogenized [OPG study]5.4951851
GSM549118patient 074, normal, homogenized [OPG study]7.4376176
GSM549129patient 027, cancer, homogenized [OPG study]4.6503232
GSM549123patient 088, normal, homogenized [OPG study]8.1596983
GSM549124patient 006, cancer, homogenized [OPG study]4.5735230
GSM549126patient 015, cancer, homogenized [OPG study]4.3431725
GSM549128patient 025, cancer, homogenized [OPG study]4.2306823
GSM549103patient 117, normal, homogenized [OPG study]6.2905762
GSM549117patient 073, normal, homogenized [OPG study]5.9359458
GSM549138patient 041, cancer, homogenized [OPG study]4.2673424
GSM549141patient 045, cancer, homogenized [OPG study]4.2921125
GSM549130patient 028, cancer, homogenized [OPG study]4.3544225
GSM549101patient 111, normal, homogenized [OPG study]6.2725562
GSM549105patient 128, normal, homogenized [OPG study]5.9273957
GSM549106patient 134, normal, homogenized [OPG study]4.284625
GSM549112patient 048, normal, homogenized [OPG study]6.3170463
GSM549125patient 011, cancer, homogenized [OPG study]4.2412222
GSM549127patient 024, cancer, homogenized [OPG study]4.8609437
GSM549135patient 035, cancer, homogenized [OPG study]5.2194245